Skip to main content
. 2019 Feb 27;25(9):1569–1576. doi: 10.1093/ibd/izz030

TABLE 4.

Logistic Regression Model for Factors Predictive of Clinical Response (ever) to Vedolizumab

Variable Odds Ratio (CI) P
Previous Anti-TNF exposure 0.5 (0.05–4.3) 0.50
Pouchitis ≤1 year after IPAA 0.3 (0.1–0.9) 0.03
Obesity 3.1 (0.6–15.5) 0.17

CI, confidence interval